Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Pingyan CHENG"'
Publikováno v:
Shipin gongye ke-ji, Vol 44, Iss 15, Pp 151-158 (2023)
Objective: Through analyzing the physicochemical properties and microbial changes of high temperature Daqu of Maotai-flavored during the storage (0~150 days), the paper aimed at comprehending the aging and maturity law of Daqu. Methods: Based on the
Externí odkaz:
https://doaj.org/article/d7075d91143b411cb5ad9ba44698ab4b
Autor:
Liang Yang, Shuangran Zeng, Meidi Zhou, Yuetao Li, Zeyuan Jiang, Pingyan Cheng, Chunlin Zhang
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Pickle like odor (PLO) is one of the main defective flavors of Maotai flavor baijiu (MFB). Understanding and controlling the PLO compounds producing strains not only solves the problem of PLO from the source, but also ensures the high-quality product
Externí odkaz:
https://doaj.org/article/10abdd074fe0416d823b6919b557ef0c
Autor:
ThuLe Trinh, William A. Adams, Alexandra Calescibetta, Nhan Tu, Robert Dalton, Tina So, Max Wei, Grace Ward, Elena Kostenko, Sean Christiansen, Ling Cen, Amy McLemore, Kayla Reed, Junmin Whitting, Danielle Gilvary, Neale Lopez Blanco, Carlos Moran Segura, Jonathan Nguyen, Wendy Kandell, Xianghong Chen, Pingyan Cheng, Gabriela M. Wright, W. Douglas Cress, Jinghong Liu, Kenneth L. Wright, Sheng Wei, Erika A. Eksioglu
Publikováno v:
iScience, Vol 26, Iss 4, Pp 106443- (2023)
Summary: Advances in the understanding of the tumor microenvironment have led to development of immunotherapeutic strategies, such as chimeric antigen receptor T cells (CAR-Ts). However, despite success in blood malignancies, CAR-T therapies in solid
Externí odkaz:
https://doaj.org/article/09130f12d9894f7784d26defbf9b2e06
Autor:
Theodore T. Drashansky, Eric Y. Helm, Nina Curkovic, Jaimee Cooper, Pingyan Cheng, Xianghong Chen, Namrata Gautam, Lingsong Meng, Alexander J. Kwiatkowski, William O. Collins, Benjamin G. Keselowsky, Derek Sant’Angelo, Zhiguang Huo, Weizhou Zhang, Liang Zhou, Dorina Avram
Publikováno v:
iScience, Vol 24, Iss 4, Pp 102307- (2021)
Summary: Mucosal-associated invariant T (MAIT) cells recognize microbial riboflavin metabolites presented by MR1 and play role in immune responses to microbial infections and tumors. We report here that absence of the transcription factor (TF) Bcl11b
Externí odkaz:
https://doaj.org/article/63f8d75804294966a5db2162dd96015a
Autor:
Wendy M Kandell, Sarah S Donatelli, Thu Le Trinh, Alexandra R Calescibetta, Tina So, Nhan Tu, Danielle L Gilvary, Xianghong Chen, Pingyan Cheng, William A Adams, Yin-Kai Chen, Jinhong Liu, Julie Y Djeu, Sheng Wei, Erika A Eksioglu
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0225820 (2020)
NK cell migration and activation are crucial elements of tumor immune surveillance. In mammary carcinomas, the number and function of NK cells is diminished, despite being positively associated with clinical outcome. MicroRNA-155 (miR-155) has been s
Externí odkaz:
https://doaj.org/article/486f94476bc74bce969117a01866caf9
Autor:
Sungjune, Kim, Evan, Wuthrick, Dukagjin, Blakaj, Zeynep, Eroglu, Claire, Verschraegen, Ram, Thapa, Matthew, Mills, Khaled, Dibs, Casey, Liveringhouse, Jeffery, Russell, Jimmy J, Caudell, Ahmad, Tarhini, Joseph, Markowitz, Kari, Kendra, Richard, Wu, Dung-Tsa, Chen, Anders, Berglund, Lauren, Michael, Mia, Aoki, Min-Hsuan, Wang, Imene, Hamaidi, Pingyan, Cheng, Janis, de la Iglesia, Robbert J, Slebos, Christine H, Chung, Todd C, Knepper, Carlos M, Moran-Segura, Jonathan V, Nguyen, Bradford A, Perez, Trevor, Rose, Louis, Harrison, Jane L, Messina, Vernon K, Sondak, Kenneth Y, Tsai, Nikhil I, Khushalani, Andrew S, Brohl
Publikováno v:
The Lancet. 400:1008-1019
Merkel cell carcinoma is among the most aggressive and lethal of primary skin cancers, with a high rate of distant metastasis. Anti-programmed death receptor 1 (anti-PD-1) and programmed death ligand 1 (PD-L1) monotherapy is currently standard of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9df26b4880352871546d5e6155e205
https://doi.org/10.1016/s0140-6736(22)01659-2
https://doi.org/10.1016/s0140-6736(22)01659-2
Autor:
Yian Ann Chen, Michael Schell, Xiuhua Zhao, Heather Cronin, Valerie Moberg, Lori McCormick, Allison Richards, Jodie Kroeger, Alberto J. Martinez, Pingyan Cheng, Bin Yu, Ragini Kudchadkar, Geoffrey Gibney, Jeffrey Weber
Gating Strategy for MDSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a33646293493acc3eb3bcdf47773880
https://doi.org/10.1158/2326-6066.22537871.v1
https://doi.org/10.1158/2326-6066.22537871.v1
Autor:
Yian Ann Chen, Michael Schell, Xiuhua Zhao, Heather Cronin, Valerie Moberg, Lori McCormick, Allison Richards, Jodie Kroeger, Alberto J. Martinez, Pingyan Cheng, Bin Yu, Ragini Kudchadkar, Geoffrey Gibney, Jeffrey Weber
Suppression of T-cell proliferation by MDSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d09f018d16c61f4fa82c6a50a599120
https://doi.org/10.1158/2326-6066.22537868.v1
https://doi.org/10.1158/2326-6066.22537868.v1
Autor:
Yian Ann Chen, Michael Schell, Xiuhua Zhao, Heather Cronin, Valerie Moberg, Lori McCormick, Allison Richards, Jodie Kroeger, Alberto J. Martinez, Pingyan Cheng, Bin Yu, Ragini Kudchadkar, Geoffrey Gibney, Jeffrey Weber
The checkpoint inhibitor nivolumab is active in patients with metastatic melanoma who have failed ipilimumab. In this phase I/II study, we assessed nivolumab's safety in 92 ipilimumab-refractory patients with unresectable stage III or IV melanoma, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7be50ee32acc2c375be484ca0085349
https://doi.org/10.1158/2326-6066.c.6548582.v1
https://doi.org/10.1158/2326-6066.c.6548582.v1
Autor:
Yian Ann Chen, Michael Schell, Xiuhua Zhao, Heather Cronin, Valerie Moberg, Lori McCormick, Allison Richards, Jodie Kroeger, Alberto J. Martinez, Pingyan Cheng, Bin Yu, Ragini Kudchadkar, Geoffrey Gibney, Jeffrey Weber
Supplementary Materials and Methods and Supplementary Table 1. This table describes the treatment characteristics of the six cohorts of patients that participated in the study described herein, including what grades of toxicity to prior ipilimumab th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ef5d952fef9109a3a55d8557be540d3
https://doi.org/10.1158/2326-6066.22537874.v1
https://doi.org/10.1158/2326-6066.22537874.v1